{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=florbetapir+F+18&page=3", "query": { "intervention": "florbetapir F 18", "page": 3 }, "page_size": 10 }, "pagination": { "page": 3, "page_size": 10, "total_count": 50, "total_pages": 5, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=florbetapir+F+18&page=4&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=florbetapir+F+18&page=2&page_size=10" }, "source": "remote", "last_synced_at": "2026-10-06T17:15:41.278Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT06600880", "title": "Neuronavigation-guided FUS-induced BBB Opening in Alzheimer's Disease Patients and Its Effects on Brain Amyloid and Tau", "overall_status": "NOT_YET_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Alzheimer Disease, Early Onset" ], "interventions": [ { "name": "Neuronavigation-guided single-element focused ultrasound transducer", "type": "DEVICE" }, { "name": "Lumason", "type": "DRUG" }, { "name": "Magnetic Resonance Imaging (MRI) with or without gadolinium contrast agents", "type": "OTHER" }, { "name": "Positron Emission Tomography (PET)", "type": "RADIATION" }, { "name": "Amyvid", "type": "DRUG" }, { "name": "MK-6240", "type": "DRUG" }, { "name": "Dotarem", "type": "DRUG" }, { "name": "Blood draw", "type": "DIAGNOSTIC_TEST" }, { "name": "UR5e", "type": "DEVICE" }, { "name": "Urine test", "type": "DIAGNOSTIC_TEST" } ], "intervention_types": [ "DEVICE", "DRUG", "OTHER", "RADIATION", "DIAGNOSTIC_TEST" ], "sponsor": "Columbia University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "50 Years", "maximum_age": null, "sex": "ALL", "summary": "50 Years and older" }, "enrollment_count": 6, "start_date": "2027-08", "completion_date": "2028-12", "has_results": false, "last_update_posted_date": "2026-05-13", "last_synced_at": "2026-10-06T17:15:41.278Z", "location_count": 1, "location_summary": "New York, New York", "locations": [ { "city": "New York", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT06600880" }, { "nct_id": "NCT07843459", "title": "A Study of LY4560736 in Healthy Participants and Participants With Alzheimer's Disease (AD)", "overall_status": "NOT_YET_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Healthy Volunteers", "Alzheimer Disease", "Amyloid", "Plaque, Amyloid", "Plasma" ], "interventions": [ { "name": "LY4560736", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" }, { "name": "Florbetapir F18", "type": "OTHER" }, { "name": "Florbetaben F 18", "type": "OTHER" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "Eli Lilly and Company", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "85 Years", "sex": "ALL", "summary": "18 Years to 85 Years" }, "enrollment_count": 111, "start_date": "2026-10", "completion_date": "2028-07", "has_results": false, "last_update_posted_date": "2026-09-28", "last_synced_at": "2026-10-06T17:15:41.278Z", "location_count": 13, "location_summary": "Anaheim, California • Irvine, California • Los Alamitos, California + 10 more", "locations": [ { "city": "Anaheim", "state": "California" }, { "city": "Irvine", "state": "California" }, { "city": "Los Alamitos", "state": "California" }, { "city": "Daytona Beach", "state": "Florida" }, { "city": "Lady Lake", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT07843459" }, { "nct_id": "NCT00702143", "title": "A Phase II Trial of 18F-AV-45 Positron Emission Tomography (PET) Imaging in Healthy Volunteers, Patients With Mild Cognitive Impairment (MCI) and Patients With Alzheimer's Disease (AD)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Alzheimer's Disease", "Mild Cognitive Impairment" ], "interventions": [ { "name": "florbetapir F 18", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Avid Radiopharmaceuticals", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "50 Years", "maximum_age": null, "sex": "ALL", "summary": "50 Years and older" }, "enrollment_count": 184, "start_date": "2008-06", "completion_date": "2008-12", "has_results": true, "last_update_posted_date": "2012-05-10", "last_synced_at": "2026-10-06T17:15:41.278Z", "location_count": 15, "location_summary": "Phoenix, Arizona • Scottsdale, Arizona • Sun City, Arizona + 12 more", "locations": [ { "city": "Phoenix", "state": "Arizona" }, { "city": "Scottsdale", "state": "Arizona" }, { "city": "Sun City", "state": "Arizona" }, { "city": "Tucson", "state": "Arizona" }, { "city": "Costa Mesa", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00702143" }, { "nct_id": "NCT04118764", "title": "Non-invasive Blood-brain Barrier Opening in Alzheimer's Disease Patients Using Focused Ultrasound", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Alzheimer Disease" ], "interventions": [ { "name": "Neuronavigation-guided single-element focused ultrasound transducer", "type": "DEVICE" }, { "name": "Definity", "type": "DRUG" }, { "name": "Magnetic Resonance Imaging (MRI) with or without gadolinium contrast agents", "type": "OTHER" }, { "name": "Positron Emission Tomography (PET)", "type": "OTHER" }, { "name": "Amyvid", "type": "OTHER" } ], "intervention_types": [ "DEVICE", "DRUG", "OTHER" ], "sponsor": "Columbia University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "50 Years", "maximum_age": null, "sex": "ALL", "summary": "50 Years and older" }, "enrollment_count": 6, "start_date": "2020-08-06", "completion_date": "2022-09-28", "has_results": true, "last_update_posted_date": "2024-08-26", "last_synced_at": "2026-10-06T17:15:41.278Z", "location_count": 1, "location_summary": "New York, New York", "locations": [ { "city": "New York", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT04118764" }, { "nct_id": "NCT01565291", "title": "A Preliminary Study of 18F-AV-45 in Alzheimer's Disease and Healthy Elderly Volunteers", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "EARLY_PHASE1" ], "conditions": [ "Alzheimer Disease" ], "interventions": [ { "name": "florbetapir F 18", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Avid Radiopharmaceuticals", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "50 Years", "maximum_age": null, "sex": "ALL", "summary": "50 Years and older" }, "enrollment_count": 32, "start_date": "2007-06", "completion_date": "2008-01", "has_results": true, "last_update_posted_date": "2012-05-18", "last_synced_at": "2026-10-06T17:15:41.278Z", "location_count": 3, "location_summary": "Baltimore, Maryland • North East, Maryland • Long Branch, New Jersey", "locations": [ { "city": "Baltimore", "state": "Maryland" }, { "city": "North East", "state": "Maryland" }, { "city": "Long Branch", "state": "New Jersey" } ], "official_url": "https://clinicaltrials.gov/study/NCT01565291" }, { "nct_id": "NCT02191267", "title": "Tau Imaging of Chronic Traumatic Encephalopathy", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Chronic Traumatic Encephalopathy" ], "interventions": [ { "name": "[F18]-T807", "type": "RADIATION" }, { "name": "[F18]-Florbetapir", "type": "RADIATION" }, { "name": "MRI/MRS", "type": "DEVICE" }, { "name": "Genetic Analysis for Genetic Risk Score for Tau.", "type": "GENETIC" } ], "intervention_types": [ "RADIATION", "DEVICE", "GENETIC" ], "sponsor": "Brigham and Women's Hospital", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "40 Years", "maximum_age": "69 Years", "sex": "MALE", "summary": "40 Years to 69 Years · Male only" }, "enrollment_count": 30, "start_date": "2015-01", "completion_date": "2016-09-30", "has_results": true, "last_update_posted_date": "2018-05-17", "last_synced_at": "2026-10-06T17:15:41.278Z", "location_count": 2, "location_summary": "Boston, Massachusetts", "locations": [ { "city": "Boston", "state": "Massachusetts" }, { "city": "Boston", "state": "Massachusetts" } ], "official_url": "https://clinicaltrials.gov/study/NCT02191267" }, { "nct_id": "NCT02051764", "title": "Imaging Characteristics of a Follow-up 18F-AV-1451 Scan", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Alzheimer's Disease" ], "interventions": [ { "name": "Flortaucipir F18", "type": "DRUG" }, { "name": "Florbetapir F 18", "type": "DRUG" }, { "name": "Brain PET Scan", "type": "PROCEDURE" } ], "intervention_types": [ "DRUG", "PROCEDURE" ], "sponsor": "Avid Radiopharmaceuticals", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "50 Years", "maximum_age": null, "sex": "ALL", "summary": "50 Years and older" }, "enrollment_count": 44, "start_date": "2014-05", "completion_date": "2016-12", "has_results": true, "last_update_posted_date": "2020-09-07", "last_synced_at": "2026-10-06T17:15:41.278Z", "location_count": 4, "location_summary": "Newport Beach, California • Orange, California • Boston, Massachusetts + 1 more", "locations": [ { "city": "Newport Beach", "state": "California" }, { "city": "Orange", "state": "California" }, { "city": "Boston", "state": "Massachusetts" }, { "city": "St Louis", "state": "Missouri" } ], "official_url": "https://clinicaltrials.gov/study/NCT02051764" }, { "nct_id": "NCT01231971", "title": "Alzheimer's Disease Neuroimaging Initiative 2", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Mild Cognitive Impairment (MCI)", "Alzheimer's Disease (AD)", "Significant Memory Concern (SMC)", "Early Mild Cognitive Impairment (EMCI)", "Late Mild Cognitive Impairment (LMCI)" ], "interventions": [ { "name": "Florbetapir", "type": "DRUG" }, { "name": "Flortaucipir", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "University of Southern California", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "55 Years", "maximum_age": "90 Years", "sex": "ALL", "summary": "55 Years to 90 Years" }, "enrollment_count": 1182, "start_date": "2011-02-14", "completion_date": "2017-11-29", "has_results": false, "last_update_posted_date": "2024-11-21", "last_synced_at": "2026-10-06T17:15:41.278Z", "location_count": 53, "location_summary": "Birmingham, Alabama • Phoenix, Arizona • Sun City, Arizona + 43 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Sun City", "state": "Arizona" }, { "city": "Irvine", "state": "California" }, { "city": "La Jolla", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT01231971" }, { "nct_id": "NCT02928211", "title": "Aftobetin-HCl and Fluorescence Detection Measured by Sapphire II to Determine the Number and Timing of Administrations", "overall_status": "UNKNOWN", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Mild Cognitive Impairment", "Alzheimer's Disease" ], "interventions": [ { "name": "Sapphire II", "type": "DEVICE" }, { "name": "Aftobetin-HCl", "type": "DRUG" }, { "name": "Positron Emission Tomography", "type": "RADIATION" } ], "intervention_types": [ "DEVICE", "DRUG", "RADIATION" ], "sponsor": "Cognoptix, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "25 Years", "maximum_age": "90 Years", "sex": "ALL", "summary": "25 Years to 90 Years" }, "enrollment_count": 105, "start_date": "2016-07", "completion_date": "2019-01", "has_results": false, "last_update_posted_date": "2018-08-22", "last_synced_at": "2026-10-06T17:15:41.278Z", "location_count": 1, "location_summary": "West Palm Beach, Florida", "locations": [ { "city": "West Palm Beach", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT02928211" }, { "nct_id": "NCT02759887", "title": "Relationship Between Down Syndrome (DS) and Alzheimer's Disease (AD)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Down Syndrome", "Alzheimer's Dementia" ], "interventions": [ { "name": "biospecimen collection", "type": "PROCEDURE" }, { "name": "cognitive assessments", "type": "OTHER" }, { "name": "caregiver questionnaire", "type": "OTHER" }, { "name": "Florbetapir F18 imaging", "type": "PROCEDURE" }, { "name": "MRI", "type": "PROCEDURE" }, { "name": "Fludeoxyglucose F18 (FDG)", "type": "PROCEDURE" }, { "name": "Tau Pet", "type": "PROCEDURE" }, { "name": "Actigraphy", "type": "PROCEDURE" } ], "intervention_types": [ "PROCEDURE", "OTHER" ], "sponsor": "St. Joseph's Hospital and Medical Center, Phoenix", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "21 Years", "maximum_age": null, "sex": "ALL", "summary": "21 Years and older" }, "enrollment_count": 19, "start_date": "2016-11", "completion_date": "2018-12", "has_results": false, "last_update_posted_date": "2019-10-29", "last_synced_at": "2026-10-06T17:15:41.278Z", "location_count": 1, "location_summary": "Phoenix, Arizona", "locations": [ { "city": "Phoenix", "state": "Arizona" } ], "official_url": "https://clinicaltrials.gov/study/NCT02759887" } ] }